Daniel R. Schimmel, MD, explains how balloon pulmonary angioplasty (BPA) uses balloons and specialized catheters to open narrowed vessels in the lungs to improve circulation and reduce symptoms…
Nick Norwitz interviews Aseem Malhotra, MD, a consultant cardiologist, on controversial new findings challenging LDL cholesterol’s role as an independent risk factor for heart disease. They discuss data…
NEW YORK (Reuters Health) – Reperfusion-induced myocardial edema during percutaneous coronary intervention for MI can be attenuated by applying ischemic conditioning at the start of reperfusion, a French…
NEW YORK (Reuters Health) – Results of a retrospective observational study reported in the Archives of Internal Medicine online June 4 indicate that in patients with atrial fibrillation,…
NEW YORK (Reuters Health) – For conversion of new-onset atrial fibrillation, intravenous amiodarone plus oral ranolazine is more effective than amiodarone alone, a Greek team reports in the…
NEW YORK (Reuters Health) – Intensive control of blood pressure does have a clinically significant positive or negative impact on depression or patient-reported health-related quality of life, according…
NEW YORK (Reuters Health) – Treatment with the antianginal drug ranolazine before elective percutaneous coronary intervention (PCI) significantly reduced procedure-related myocardial injury in a small pilot study from…
NEW YORK (Reuters Health) – Compared with unfractionated heparin (UFH) monotherapy, bivalirudin use in patients undergoing percutaneous coronary intervention via the femoral artery is associated with significantly decreased…
NEW YORK (Reuters Health) – Contrary to some study findings, statin therapy does not increase the risk of intracerebral hemorrhage (ICH) significantly, according to the results of a…
NEW YORK (Reuters Health) – For the millions of patients who come to the ED each year complaining of chest pain, an accelerated diagnostic protocol can accurately identify…
NEW YORK (Reuters Health) – Treating all patients at intermediate cardiovascular risk with a moderate-dose statin would decrease adverse cardiovascular events to the same extent as a prevention…
NEW YORK (Reuters Health) – Results of a new meta-analysis indicate that all drug-eluting stents (DES) outperform bare metal stents (BMS) over both the short and long term,…
